WWA
BSX icon

Wingate Wealth Advisors’s Boston Scientific BSX Stock Holding History

Wingate Wealth Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,686
Closed -$151K – 140
2024
Q4 		$151K Buy
+1,686
New +$148K 0.15% 114

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wingate Wealth Advisors's BSX Position: Q1 2025 in Review

Wingate Wealth Advisors sold out of Boston Scientific (BSX) in Q1 2025, closing a stake of 1,686 shares — an estimated $151K sold.

Wingate Wealth Advisors first reported a position in BSX in Q4 2024 and held it in 1 quarter. The position peaked at $151K in Q4 2024. 1,642 funds tracked by Wall St. Rank hold BSX as of Q1 2025.

  • Wingate Wealth Advisors reported no remaining Boston Scientific position as of Q1 2025 after selling out during the quarter.
  • Wingate Wealth Advisors sold 1,686 Boston Scientific shares in Q1 2025, an estimated $151K.
  • Wingate Wealth Advisors first reported a position in Boston Scientific in Q4 2024 and held it in 1 quarter.
  • Wingate Wealth Advisors's Boston Scientific position peaked at $151K in Q4 2024.
  • 1,642 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2025.

Based on Wingate Wealth Advisors's 13F filing for Q1 2025, filed 24 Apr 2025.